MmpL3-IN-1, also known as compound 32, is a highly effective inhibitor of Mycobacterial membrane protein large 3 (MmpL3). With an anti-tuberculosis activity exhibiting a minimum inhibitory concentration (MIC) of less than 0.016 μg mL in M. tuberculosis, MmpL3-IN-1 is a valuable compound for research on drug-resistant tuberculosis [1].
MSU-43085, an orally active MmpL3 inhibitor targeting Mycobacterium tuberculosis (Mtb), demonstrates effective inhibition of Mtb in an acute murine tuberculosis infection model. This compound is applicable in tuberculosis research [1].